Patient Pathfinder: Clinical Trials
Clinical Trials for Bladder Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 278 active Bladder Cancer trials
Lifestyle Change for Better Health
Study Type: Interventional
A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy
Study Type: Interventional Phase 2
MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment
Study Type: Observational
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
Study Type: Observational
Measuring Taste Perception During Chemotherapy for Muscle Invasive Bladder Cancer
Study Type: Observational
Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade
Study Type: Interventional
Recovery Support for Bladder Cancer Patients and Caregivers
Study Type: Interventional
Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder
Study Type: Interventional Phase 2
There are 278 active Bladder Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now